Individual and group % of enrollees 18 years of age or younger with claims for any Research/STABLE C ≥ 6 psychotherapy outpatient visits by a mental health practitioner within 84-days (12 weeks) of initial diagnosis Attention-Deficit Hyperactivity Disorder Follow-up care during initiation % of members age 6 to 18 with a new prescription for an ADHD NCQA B phase medication who had 1 follow-up visit with a prescribing practitioner ≥ within 30 days of the index prescription date Follow-up during continuation % of members 6 to 18 years of age with a new prescription for ADHD NCQA B phase medication who remained on the medication for at least 210 days and had at least two follow-up visits with a prescribing practitioner within 270 days (9 months) after the initiation phase ended. Use of stimulant medication for % of enrollees 18 years of age or younger diagnosed with ADHD who APA/CQAIMH B ADHD receive a stimulant medication during the measurement year Preschoolers Use of antipsychotics in % of enrollees under 2 to 5 years of age who are prescribed an PSYCKES/TEXAS/ C preschoolers antipsychotic medication during the measurement year MMDLN/Rutgers CERTS Psychosocial visits prior to initiation % of enrollees 2 to 5 years of age who receive 6 outpatient visits prior to PSYCKES/TEXAS C of medication initiating psychotropic (antidepressants, stimulants, antipsychotics) medication treatment Psychosocial visits after initiation of % of enrollees 2-5 years of age who receive 6 outpatient visits after PSYCKES/TEXAS C ≥ medication initiation of psychotropic medications (antidepressants, stimulants, antipsychotics)
Individual and group psychotherapy % of enrollees 18 years of age or younger with ≥ 6 claims for any outpatient visits by a mental health practitioner within 84-days (12 weeks) of initial diagnosis Research/STABLE C Attention-Deficit Hyperactivity Disorder Follow-up care during initiation phase Follow-up during continuation phase Use of stimulant medication for ADHD % of members age 6 to 18 with a new prescription for an ADHD medication who had ≥ 1 follow-up visit with a prescribing practitioner within 30 days of the index prescription date % of members 6 to 18 years of age with a new prescription for ADHD medication who remained on the medication for at least 210 days and had at least two follow-up visits with a prescribing practitioner within 270 days (9 months) after the initiation phase ended. % of enrollees 18 years of age or younger diagnosed with ADHD who receive a stimulant medication during the measurement year NCQA NCQA APA/CQAIMH B B B Preschoolers Use of antipsychotics in preschoolers Psychosocial visits prior to initiation of medication Psychosocial visits after initiation of medication % of enrollees under 2 to 5 years of age who are prescribed an antipsychotic medication during the measurement year % of enrollees 2 to 5 years of age who receive 6 outpatient visits prior to initiating psychotropic (antidepressants, stimulants, antipsychotics) medication treatment % of enrollees 2-5 years of age who receive ≥ 6 outpatient visits after initiation of psychotropic medications (antidepressants, stimulants, antipsychotics) PSYCKES/TEXAS/ MMDLN/Rutgers CERTS PSYCKES/TEXAS PSYCKES/TEXAS C C C